Rituxan warning

FDA Consum. Mar-Apr 2007;41(2):3.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Murine-Derived
  • Drug Labeling
  • Humans
  • Immunologic Factors / adverse effects*
  • Leukoencephalopathy, Progressive Multifocal / chemically induced*
  • Lupus Erythematosus, Systemic / drug therapy*
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab